本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Impact Biomedical, Inc.

0.6360
-0.0086-1.33%
盤後0.63940.0034+0.53%19:36 EDT
成交量:10.93萬
成交額:6.99萬
市值:774.99萬
市盈率:-0.19
高:0.6446
開:0.6330
低:0.6330
收:0.6446
52周最高:6.17
52周最低:0.3621
股本:1,218.54萬
流通股本:1,173.81萬
量比:1.11
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-3.2639
每股收益(LYR):-2.2969
淨資產收益率:-405.44%
總資產收益率:-8.24%
市淨率:-0.75
市盈率(LYR):-0.28

資料載入中...

2023/10/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/10/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

SEC問詢函

Form CORRESP - Correspondence
2023/08/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/24

SEC問詢函

Form CORRESP - Correspondence
2023/06/30

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/06/30

SEC問詢函

Form CORRESP - Correspondence
2023/06/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/06/21

SEC問詢函

Form CORRESP - Correspondence
2023/06/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/06/02

SEC問詢函

Form CORRESP - Correspondence
2023/05/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/01/31

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/01/31

SEC問詢函

Form CORRESP - Correspondence
2023/01/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/01/09

SEC問詢函

Form CORRESP - Correspondence